Skorpios Trust
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 30, 2025), Skorpios Trust reported 2 stock positions worth $37.1 million. Its top holding was Stoke Therapeutics (STOK) at 99.6% of the portfolio, followed by SS SPDR S&P Biotech ETF (XBI, 0.4%). Compared with Q1 2025, it reduced 1. The biggest sale was Stoke Therapeutics (STOK, shares −53%).
- Most Recent 13F
- Q3 2025
- Location
- LIMASSOL, G4
- CIK
- 0001869333
- Portfolio Value
- $37.1M (Q2 2025)
- SEC Filing
- 0001123292-25-000327 ↗ filed Jul 30, 2025
Holdings Value
Holdings 2 stocks · $37.1M
Portfolio Sells Q1 2025 → Q2 2025
| STOK Stoke Therapeutics Inc. | Reduce -52.9% | 99.62% | −0.08 |
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||